Pemetrexed
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
67184-0504 -
Package NDC
67184-0504-1 -
Application number
ANDA204890 -
SPL ID
0dc735ab-c4c9-4e19-bb80-8a439be7208c -
SPL set ID
46a9b89d-7135-4e0c-b8e4-52580554769b -
UNII
F4GSH45R4C -
RxCUI
1728072 -
RxCUI
1728077
What the source publishes
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Active ingredients
- Pemetrexed disodium
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Pemetrexed",
"splId": "0dc735ab-c4c9-4e19-bb80-8a439be7208c",
"labels": [
{
"setId": "46a9b89d-7135-4e0c-b8e4-52580554769b",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=46a9b89d-7135-4e0c-b8e4-52580554769b",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=46a9b89d-7135-4e0c-b8e4-52580554769b"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Qilu Pharmaceutical Co., Ltd.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL in 1 CARTON (67184-0504-1) / 20 mL in 1 VIAL",
"package_ndc": "67184-0504-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20220525"
}
],
"productId": "67184-0504_0dc735ab-c4c9-4e19-bb80-8a439be7208c",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "67184-0504",
"deaSchedule": null,
"genericName": "Pemetrexed disodium",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "PEMETREXED DISODIUM HEMIPENTAHYDRATE",
"strength": "500 mg/20mL"
}
],
"applicationNumber": "ANDA204890",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220525",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"F4GSH45R4C"
],
"rxcui": [
"1728072",
"1728077"
],
"spl_set_id": [
"46a9b89d-7135-4e0c-b8e4-52580554769b"
],
"manufacturer_name": [
"Qilu Pharmaceutical Co., Ltd."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:67184-0504_0dc735ab-c4c9-4e19-bb80-8a439be7208c"